Valeant Pharma (VRX) ex-CEO, ex.-CFO Said to Be Focus of Criminal Probe
Tweet Send to a Friend
(Updated - October 31, 2016 3:32 PM EDT)Valeant Pharma (NYSE: VRX) ex-CEO, Michael Pearson and ex.-CFO, Howard Schiller, are said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
